This blog explores the relationship between cancer and diabetes. We differentiate the risk of cancer for people with type 1 and type 2 diabetes. Lastly, we explore the importance of diabetes educators in promoting lifestyle change and being involved early detection and cancer prevention.
Together, we can help those living with diabetes take early action and get appropriate screenings!
Type 1 and Type 2 Diabetes
What’s the Link?
Cancer is the 2nd Leading Cause of Death in the United States.
Diabetes is the 7th leading cause of death.
What is the intersection between diabetes and cancer?
In 2010, Diabetes and Cancer, a Consensus Statement was the first official report that brought this connection to light. Since that initial publication, our understanding of this co-relationship continues to evolve. This article highlights these newer findings.
There are risk factors that are common to both diseases:
In addition, there are some possible mechanisms for a direct link. People with diabetes and cancer share:
In both conditions, cellular inflammation exists and some researchers have suggested that the abundance of glucose feeds hungry tumor cells.
Cancer and Diabetes Rates
Type 1 Diabetes and Cancer – Risk Compared to general population.
Increased Cancer Risk of:
Decreased Cancer Risk of:
Type 2 Diabetes and Cancer – Risk Compared to general population.
Increased Cancer Risk of:
Decreased Cancer Risk of:
Prevention and Screenings are Critical
Since the link between diabetes and cancer seems to be due in part to shared risk factors such as obesity, diet and inactivity, we can continue to promote the usual lifestyle adjustments:
Diabetes Medications and Cancer
Some diabetes medications should not be used in patients at risk of certain cancers.
Download Medication PocketCard for reference »
Metformin may have some cancer protective qualities.
Metformin is a plant based derivative. It originates from French Lilac, Galega Officinalis.
Results of a growing number of observational human studies suggest that treatment with metformin (relative to other glucose-lowering therapies) is associated with reduced risk of cancer or cancer mortality.
There are trials underway to see if metformin is associated with slowing cellular aging and increasing telomere length.
As diabetes educators, we can help increase awareness of the association between cancer and diabetes. We can inform and advocate to make sure patients get appropriate screenings with a focus on early detection.
Want to learn more?
Join us to explore the relationship between cancer and diabetes and to use a case study approach to determine best strategies to manage hyperglycemia during chemotherapy on steroids.
Diabetes and Cancer Course – Earn 1.5 CEs >>
This On Demand Presentation now available
Earn 1.5 CEs and learn more about this important topic.